ACTRN12612000144819尚未招募未知
A randomized parallell group cross-over study of the effect of the use of two blood glucose monitoring systems (Accu-Chek Mobile and Optium Exeed) in patients with type one diabetes on the frequency of blood glucose monotoring and patient satisfaction.
Roche Diagnostics Australia Pty Ltd0 个研究点目标入组 50 人开始时间: 2012年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- All
入选标准
- •1. Type 1 diabetes diagnosed for greater than or equal to one year
- •2. Known to the study site (ie. attended for clinical care greater than or equal to 2 visits in the last 2 years)
- •3. Glycosylated haemoglobin (HbA1c) greater than or equal to 7.5 %
- •4. Aged 18-45 years
- •5. Their health care professional recommends that they monitor greater than or equal to 4 times a day
- •5. They are performing some monitoring but less than 21 blood glucose estimations per week
- •6. They are able to understand, read and write English without assistance
- •7. They are willing to attend for all of the scheduled study visits
- •8. They are prepared to use the two blood glucose monitoring systems being used in the study.
排除标准
- •1. Type 2 diabetes
- •2. Use of oral or inhaled steroids
- •3 They are pregnant or planning a pregnancy
- •4. They have an infection
- •5. medical condition, such as cancer, severe depression or other psychological conditions that, in the opinion of the investigators, makes the person unsuitable for inclusion in the study.
研究者
相似试验
进行中（未招募）
1 期
A randomised parallel group study to investigate the effect of Seretide withdrawal in COPD using non-invasive biomarkers and physiological measurements - The effect of Seretide withdrawal on lung inflammation in COPDChronic Obstructive Pulmonary DiseaseEUCTR2004-003833-15-GBSouth Manchester University NHS Trust24
进行中（未招募）
不适用
A pragmatic, randomized, parallel group study of the effect on disease remission, work productivity, and tolerability of tocilizumab in combination with DMARDs and individually designed best practice DMARD therapy in patients with early, moderate to severe Rheumatoid ArthritisMedDRA version: 12.1Level: LLTClassification code 10039073Term: <Manually entered code. Term in E.1.1>Rheumatoid Arthritis (RA)EUCTR2010-019935-37-FIRoche Oy160
已完成
1 期
A randomised, two-way crossover study to compare the pharmacokinetics of testosterone following application of a Testosterone Metered Dose (MD) lotion or AndroGel in men with low serum testosteroneACTRN12605000517673Acrux DDS Pty Ltd6
进行中（未招募）
1 期
A randomised, double blinded, crossover study of the influence of Metoprolol on exercise induced elevation of catecholamines in healthy subjects. - MEXICHOEUCTR2008-001908-23-DKRigshospitalet, Department of Clinical Pharmacology30
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of switching from regular infliximab to biosimilar infliximab in patients with rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn's disease and psoriasisEUCTR2014-002056-40-NODiakonhjemmet Hospital AS498